| Parenteral Drugs (India) Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524689 |
NSE Symbol : PDPL |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE904D01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -300.60 |
Market Cap(₹Cr) : 10.11 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Gross Sales | 1.77 | 1.44 | 2.35 | 2.93 | 2.57 | 2.04 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1.77 | 1.44 | 2.35 | 2.93 | 2.57 | 2.04 |
| Other Operating Income | 0.04 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 |
| Other Income | 52.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 54.02 | 1.45 | 2.36 | 2.94 | 2.60 | 2.05 |
| Total Expenditure | 7.66 | 4.67 | 5.62 | 5.57 | -0.82 | 4.91 |
| PBIDT | 46.37 | -3.21 | -3.26 | -2.62 | 3.42 | -2.86 |
| Interest | 0.00 | 36.68 | 35.47 | 34.10 | 32.46 | 32.09 |
| PBDT | 46.36 | -39.90 | -38.72 | -36.72 | -29.04 | -34.95 |
| Depreciation | 27.15 | 4.33 | 4.33 | 4.33 | 4.32 | 4.34 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -4.60 | -9.70 | -9.44 | -9.02 | -8.51 | -8.31 |
| Reported Profit After Tax | 23.81 | -34.52 | -33.61 | -32.04 | -24.84 | -30.97 |
| Extra-ordinary Items | 52.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -28.40 | -34.52 | -33.61 | -32.04 | -24.84 | -30.97 |
| EPS (Unit Curr.) | 7.99 | -11.58 | -11.28 | -10.74 | -8.33 | -10.41 |
| EPS (Adj) (Unit Curr.) | 7.99 | -11.58 | -11.28 | -10.74 | -8.33 | -10.41 |
| Calculated EPS (Unit Curr.) | 7.99 | -11.58 | -11.27 | -10.74 | -8.33 | -10.39 |
| Calculated EPS (Adj) (Unit Curr.) | 7.99 | -11.58 | -11.27 | -10.74 | -8.33 | -10.39 |
| Calculated EPS (Ann.) (Unit Curr.) | 31.95 | -46.32 | -45.09 | -42.98 | -33.33 | -41.55 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 31.95 | -46.32 | -45.09 | -42.98 | -33.33 | -41.55 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 29.82 | 29.82 | 29.82 | 29.82 | 29.82 | 29.82 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 2,619.77 | -222.92 | -138.72 | -89.42 | 133.07 | -140.20 |
| PBDTM(%) | 2,619.21 | -2,770.83 | -1,647.66 | -1,253.24 | -1,129.96 | -1,713.24 |
| PATM(%) | 1,345.20 | -2,397.22 | -1,430.21 | -1,093.52 | -966.54 | -1,518.14 |